Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $7.68B | $7.87B | $8.39B | $14.4B |
| Revenue growth | — | 2.5% | 6.6% | 71.6% |
| Operating income | $121M | $57.0M | $291M | $480M |
| Operating margin | 1.6% | 0.7% | 3.5% | 3.3% |
| Net income | -$84.0M | -$314M | -$82.0M | $66.0M |
| Net margin | -1.1% | -4.0% | -1.0% | 0.5% |
| EPS (diluted) | -$0.93 | -$3.49 | -$0.90 | $0.27 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | $126M | $67.0M | $47.0M | $543M |
| Capital expenditures | $18.0M | $12.0M | $11.0M | $27.0M |
| Free cash flow | $108M | $55.0M | $36.0M | $516M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $366M | $305M | $452M | $437M |
| Total assets | — | $6.41B | $12.0B | $11.5B |
| Total liabilities | — | $6.00B | $7.42B | $6.84B |
| Long-term debt | — | $4.07B | $4.64B | $3.90B |
| Shareholders' equity | $706M | $375M | $4.46B | $4.50B |
| Retained earnings | — | -$445M | -$527M | -$461M |
| Shares (wtd avg diluted) | 90.0M | 90.0M | 91.0M | 244M |
Every figure is extracted from Amentum Holdings, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.